Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor

Thalidomide is an inhibitor of angiogenesis.

Robert J. D’Amato, Michael Loughnan, Evelyn Flynn et al. · Proceedings of the National Academy of Sciences · 1994 · 2.5K citations · Full text

Angiogenesis, Developmental Biology, Ophthalmology +13

Definition of Two Angiogenic Pathways by Distinct α _v Integrins

Martin Friedlander, Peter C. Brooks, Robert W. Shaffer et al. · Science · 1995 · 1.3K citations

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.

E P Sampaio, Euzenir Nunes Sarno, Ruth Galilly et al. · The Journal of Experimental Medicine · 1991 · 1.2K citations · Full text

Toxic Effects, Immune Regulation, Immunology +22

Treatment of Pulmonary Hemangiomatosis with Recombinant Interferon Alfa-2a

Carl W. White, Henry M. Sondheimer, Edmond C. Crouch et al. · New England Journal of Medicine · 1989 · 437 citations

Pulmonary Embolism, Pulmonary Arterial Hypertension, Antifibrotic Therapy +15

Thalidomide for the Treatment of Chronic Graft-versus-Host Disease

Georgia B. Vogelsang, Evan R. Farmer, Allan D. Hess et al. · New England Journal of Medicine · 1992 · 393 citations · Full text